192 filings
6-K
NCNA
NuCana plc
16 Apr 24
NuCana Announces Completion of ADS Ratio Change
8:08am
6-K
NCNA
NuCana plc
9 Apr 24
NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy
4:43pm
F-6 POS
NCNA
NuCana plc
27 Mar 24
Automatic registration for ADRs (post-effective amendment, foreign)
5:17pm
424B5
NCNA
NuCana plc
27 Mar 24
Prospectus supplement for primary offering
4:47pm
6-K
NCNA
NuCana plc
27 Mar 24
NuCana Announces Plan to Implement ADS Ratio Change
4:39pm
20-F
2023 FY
NCNA
NuCana plc
Annual report (foreign)
20 Mar 24
4:30pm
6-K
NCNA
NuCana plc
20 Mar 24
NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update
4:12pm
SC 13D/A
Sofinnova Venture Partners VIII, L.P.
27 Feb 24
NuCana / Sofinnova Venture Partners VIII ownership change
4:29pm
SC 13G/A
Griffith Hugh
14 Feb 24
NuCana / Griffith Hugh ownership change
4:26pm
SC 13G/A
Baillie Gifford & Co
26 Jan 24
NuCana / BAILLIE GIFFORD & CO ownership change
6:31am
6-K
NCNA
NuCana plc
16 Nov 23
Unaudited Condensed Consolidated Statements of Operations
4:08pm
6-K
NCNA
NuCana plc
13 Nov 23
NuCana Announces Listing Transfer to Nasdaq Capital Market
4:22pm
6-K
NCNA
NuCana plc
16 Oct 23
NuCana Presents Promising Data on NUC-7738 at the AACR-NCI-EORTC
7:10am
6-K
NCNA
NuCana plc
13 Oct 23
NuCana Presents Encouraging Data on NUC-3373 in Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023
4:09pm
6-K
NCNA
NuCana plc
18 Sep 23
NuCana Announces Presentations at the AACR-NCI-EORTC International
8:10am
6-K
NCNA
NuCana plc
16 Aug 23
Unaudited Condensed Consolidated Statements of Operations
4:08pm
6-K
NCNA
NuCana plc
16 Jun 23
Current report (foreign)
8:00am
6-K
NCNA
NuCana plc
17 May 23
Unaudited Condensed Consolidated Statements of Operations
4:07pm
6-K
NCNA
NuCana plc
15 May 23
Current report (foreign)
4:11pm
6-K
NCNA
NuCana plc
12 May 23
NuCana Announces Receipt of Nasdaq Notice
4:15pm